Wave Life Sciences, Inc. SEC filings WVE
Wave Life Sciences, Inc. has 743 filings in SEC EDGAR's recent list, going back to Feb 2, 2015. Its latest annual report, Form ARS, was filed on Oct 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| 424B5 | Prospectus supplement | Dec 11, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| S-8 | Employee stock plan registration | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 12, 2024 | — |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 24, 2024 | — |
| 424B3 | Prospectus | Sep 24, 2024 | — |
| 424B5 | Prospectus supplement | Dec 8, 2023 | — |
| 424B5 | Prospectus supplement | Dec 6, 2023 | — |
| S-8 | Employee stock plan registration | Nov 9, 2023 | — |
| S-8 | Employee stock plan registration | Nov 9, 2023 | — |
| S-8 | Employee stock plan registration | Nov 10, 2022 | — |
| 424B5 | Prospectus supplement | Jun 14, 2022 | — |
| S-3 | Shelf registration | Mar 3, 2022 | — |
| S-8 | Employee stock plan registration | Nov 10, 2021 | — |
| S-8 | Employee stock plan registration | Aug 31, 2021 | — |
| 424B5 | Prospectus supplement | Sep 23, 2020 | — |
| 424B5 | Prospectus supplement | Sep 22, 2020 | — |
| S-8 | Employee stock plan registration | Aug 10, 2020 | — |
| S-8 | Employee stock plan registration | Aug 10, 2020 | — |
| POS AM | Filing | Mar 2, 2020 | — |
| S-8 | Employee stock plan registration | Nov 5, 2019 | — |
| S-8 | Employee stock plan registration | Aug 6, 2019 | — |
| S-3 | Shelf registration | Aug 6, 2019 | — |
| S-3ASR | Automatic shelf registration | May 10, 2019 | — |
| 424B5 | Prospectus supplement | Jan 24, 2019 | — |
| 424B5 | Prospectus supplement | Jan 23, 2019 | — |
| S-8 | Employee stock plan registration | Nov 9, 2018 | — |
| S-8 | Employee stock plan registration | Nov 9, 2017 | — |
| 424B5 | Prospectus supplement | Apr 12, 2017 | — |
| 424B5 | Prospectus supplement | Apr 11, 2017 | — |
| 424B2 | Prospectus | Feb 6, 2017 | — |
| S-3/A | Filing | Jan 27, 2017 | — |
| S-3 | Shelf registration | Jan 4, 2017 | — |
| S-8 | Employee stock plan registration | Dec 17, 2015 | — |
| 424B1 | Filing | Nov 12, 2015 | — |
| S-1MEF | S-1 mef | Nov 10, 2015 | — |
| S-1/A | Amended registration statement | Nov 10, 2015 | — |
| S-1/A | Amended registration statement | Nov 9, 2015 | — |
| S-1/A | Amended registration statement | Nov 6, 2015 | — |
| S-1/A | Amended registration statement | Nov 2, 2015 | — |
| S-1/A | Amended registration statement | Oct 23, 2015 | — |
| S-1 | Registration statement | Oct 9, 2015 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- WVE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1631574
- Former names
- Wave Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences LTD. (until Jul 30, 2026); WAVE Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences Pte Ltd (until Nov 2, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.